CLOUDBREAK THERAPEUTICS LLC

IPO

Seeing Life Better Through Medicine

Public · Irvine, United States · Founded 2018

Headquarters
Irvine, California
Employees
1–10
Founded
2018
Business Model
B2B
Last Round
Grant
Rounds
5
Type
Public

About

Cloudbreak Pharma is a clinical-stage ophthalmic biopharmaceutical company developing topical eye drop treatments for chronic eye diseases with limited therapeutic options. Their lead candidate CBT-001, a multi-kinase inhibitor, targets pterygium and related anterior segment diseases. The company has licensing partnerships with Santen Pharmaceutical and Grand Pharma.

Summary

CLOUDBREAK THERAPEUTICS LLC is a Biotech company based in Irvine, United States, founded in 2018. Investors include National Institutes of Health and DYEE Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOSep 2025
$78.0M

Sign up to see all 6 rounds

Grant through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CLOUDBREAK THERAPEUTICS LLC on Indexed.vc
<a href="https://indexed.vc/companies/cloudbreak-therapeutics-llc"><img src="https://indexed.vc/api/badge/company/cloudbreak-therapeutics-llc" alt="CLOUDBREAK THERAPEUTICS LLC on Indexed.vc" width="260" height="76" /></a>